Michael Szulc

home / authors / michael-szulc

Articles

Part VII GMPs for Small Molecule Drugs in Early Development Workshop Summary

Part VII GMPs for Small Molecule Drugs in Early Development Workshop Summary

Q. Chan Li;Mark D. Trone;Jackson Pellett;Michael Szulc;Kirby Wong-Moon
December 2nd 2014

The authors explore and define common industry approaches and practices when applying GMPs in early development.

GMPs for Small-Molecule Drugs in Early Development: Workshop Summary-Part VI

GMPs for Small-Molecule Drugs in Early Development: Workshop Summary-Part VI

Q. Chan Li;Mark D. Trone;Jackson Pellett;Michael Szulc;Kirby Wong-Moon
November 2nd 2014

The authors explore and define common industry approaches and practices when applying GMPs in early development.

Early Development GMPs for Small-Molecule Specifications: An Industry Perspective (Part V)

Early Development GMPs for Small-Molecule Specifications: An Industry Perspective (Part V)

Dennis O'Connor;James S. McElvain;Mark D. Trone;Michael Coutant;Michael Szulc;Mehran Yazdanian;Shuhong Zhang;Scott A. Miller;Peter Yehl;Kirby Wong-Moon;Zhihong Ge;Frank Swanek
October 2nd 2012

IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development.

GMPs for Method Validation in Early Development: An Industry Perspective (Part II)

GMPs for Method Validation in Early Development: An Industry Perspective (Part II)

Brent Kleintop;Mark D. Trone;Michael Szulc;Donald Chambers;Kristin Patterson;Gary Guo;Henrik Rasmussen;Steve Deegan;John Spicuzza;Steven Nowak;Zhanna Yuabova;Karla Tombaugh
July 2nd 2012

IQ Consortium representatives explore industry approaches for applying GMPs in early development.

Latest Updated Articles

Document Review and Quality Control Concept. Document with a checkmark, quality assurance, and process control. auditing, compliance, verification, data inspection, and business workflow management. | Image Credit: © Supatman - stock.adobe.com
Published: July 4th 2025 | Updated: August 28th 2025
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
Inside Lonza CHI’s Innovation Strategy: Future-Ready Capsules for Complex Drugs
Published: April 21st 2025 | Updated: June 17th 2025
Inside Lonza CHI’s Innovation Strategy: Future-Ready Capsules for Complex Drugs
3d rendering of Antibody drug conjugates (ADCs) are targeted medicines that deliver chemotherapy agents to cancer cells | Image Credit: © Love Employee - © Love Employee- stock.adobe.com
Published: February 4th 2025 | Updated: March 3rd 2025
Advancing ADCs to the Next Level
CPHI Milan 2024: New Developments in ADC Technologies
Published: October 10th 2024 | Updated: March 3rd 2025
CPHI Milan 2024: New Developments in ADC Technologies
TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com
Published: January 10th 2025 | Updated: January 13th 2025
Cavazzoni Retires as CDER Director
Buy, Sell, Hold: Cell and Gene Therapy
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
© 2025 MJH Life Sciences

All rights reserved.